HLA class II transgenic mouse models for S. aureus infections and superantigens
HLA class II transgenic mouse models for S. aureus infections and superantigens
批准号:
8366719
负责人:
CHELLA S DAVID
金额:
$39.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2017-04-30
关键词:
AddressAllelesAnimal ModelAntibiotic ResistanceAntibodiesBacteriaBenignBindingBiochemicalBiologicalBone MarrowCellsChimera organismClinicalDiseaseDisease OutcomeEnterocytesExotoxinsExposure toFamilyFunctional disorderGenetic PolymorphismGoalsHLA-DQ AntigensHLA-DQ6HLA-DQ8 antigenHLA-DR AntigensHLA-DR2 AntigenHLA-DR3 AntigenHLA-DR4 AntigenHealthHumanImmune responseImmunityImmunologic MarkersIncidenceIndividualInfectionInfectious Skin DiseasesInflammationInstitutesInterferon Type IIInterferonsIntestinesInvestigationKidneyLifeLiverLungMHC Class II GenesMediatingMediator of activation proteinMindModelingMolecularMouse StrainsMusOrganOrganismOutcomePathogenesisPathogenicityPathologyPathway interactionsPatientsPlayPneumoniaPrevention strategyProductionResistanceRoleRouteSepsisSeriesStaphylococcal Enterotoxin BStaphylococcus aureusStreptococcus pyogenesSuperantigensSyndromeT-Cell ActivationT-LymphocyteTNFRSF10A geneTherapeuticTherapeutic UsesTimeToxic Shock SyndromeToxinTransgenic MiceVirulencechemokinecohortcytokineimmunopathologyin vivoinsightinterestmethicillin resistant Staphylococcus aureusmortalitymouse modelnovelreceptorresistant strainresponseweapons
中文摘要
描述(申请人提供):金黄色葡萄球菌是一种普遍存在的革兰氏阳性微生物,涉及一系列疾病;从良性的局部皮肤感染到危及生命的全身疾病,包括肺炎、败血症和经期或非经期中毒性休克综合征(TSS)。金黄色葡萄球菌的毒力和致病性归因于其几种外毒素。超抗原外毒素(SAG)是其中重要的一种,因为SAG是已知的最有效的T淋巴细胞激活剂。某些SAG也可以用作生物武器。因此,从多个角度来看,SAG都很重要。然而,由于缺乏良好的动物模型,SAG参与该病发病的分子途径尚不完全清楚。由于SAG与小鼠MHC II类分子结合较差,常规小鼠株对TSS具有抗药性。然而,SAG能更有效地与人MHC I类分子结合。因此,转基因表达HLAII类分子的小鼠很容易屈服于SAG通过不同途径传递的致病作用和金黄色葡萄球菌感染。由于SAG在人类白细胞抗原II类(HL A-DR3)转基因小鼠体内引起的疾病也与人类相似,是理想的动物模型。利用这个小鼠模型,我们已经证明了干扰素-γ(IFN-?)依赖的小肠病理在与TSS相关的致命性中起着关键作用。然而,干扰素在TSS中直接或间接通过其他介体促进致死性的分子途径尚不清楚。因此,建议(1)阐明干扰素-β在葡萄球菌SAG诱导的TSS中起致死作用的机制。这将通过在人类白细胞抗原-DR3、干扰素-?R+/+和人类白细胞抗原-DR3.干扰素?R-/-小鼠之间产生骨髓嵌合体来实现。骨髓嵌合体将被SEB挑战,并将比较几种分子途径。然而,干扰素-?对金黄色葡萄球菌感染的免疫也很重要。因此,建议(2)确定干扰素的作用。在耐甲氧西林金黄色葡萄球菌肺炎和败血症的发病机制和免疫中的作用。这将通过用MRSA分离株USA300诱导人类白细胞抗原-DR3、干扰素?+/+和人类白细胞抗原-DR3、干扰素??R-/-小鼠的肺炎和败血症来实现。我们将在这两个品系的小鼠之间比较一些细菌学、免疫学、生化和病理学参数,包括死亡率。已知人类白细胞抗原II类基因多态性可强烈影响T细胞活化和干扰素的大小。对链球菌SAG的反应生产。然而,人类白细胞抗原-DR和人类白细胞抗原-DQ基因多态性对葡萄球菌SAG诱导的免疫应答的影响尚未被研究。因此,建议(3)确定葡萄球菌超抗原诱导的干扰素-?人类白细胞抗原II类基因的产生受到调节,从而影响耐甲氧西林金黄色葡萄球菌引起的肺炎和败血症的结局。这将通过一系列体内研究来进行,这些转基因小鼠表达了人类白细胞抗原DR2、人类白细胞抗原DR3、人类白细胞抗原DR4、人类白细胞抗原DQ2、人类白细胞抗原DQ6或人类白细胞抗原DQ8分子。
公共卫生相关性:金黄色葡萄球菌是一种常见但具有潜在危险的细菌。由抗生素耐药菌株引起的严重感染在全球范围内呈上升趋势,这可能部分归因于这些菌株产生多种有害毒素的能力。这项研究调查了一种被称为“超抗原”的毒素家族的作用机制。此外,某些人在感染金黄色葡萄球菌后可能会有不同结果的原因以及如何产生的原因将使用我们的人源化小鼠进行研究。
英文摘要
DESCRIPTION (provided by applicant): Staphylococcus aureus is a ubiquitous Gram-positive organism implicated in a spectrum of diseases; from benign, localized skin infections to life-threatening, systemic illnesses including pneumonia, sepsis and menstrual or non-menstrual toxic shock syndromes (TSS). The virulence and pathogenicity of S. aureus is attributed to its several exotoxins. The superantigen exotoxins (SAg) are important amongst them because SAg are the most potent activators of T lymphocytes known. Certain SAg could also be used as biological weapons. Thus, SAg are important from many perspectives. Nonetheless, the molecular pathways by which SAg participate in the disease pathogenesis have not been completely understood due to lack of good animal models. The conventional mouse strains are resistant to TSS due to poor binding of SAg to mouse MHC class II. However, SAg binds more efficiently to human MHC (called HLA) class I molecules. Therefore, mice transgenically expressing HLA class II molecules readily succumb to the pathogenic effects of SAg delivered through different routes and to S. aureus infection. As the disease caused by SAg in HLA class II (HLA-DR3) transgenic mice also closely mimics the syndrome in humans, they are ideal models. Using this mouse model we have demonstrated that interferon-gamma (IFN-?) dependent small intestinal pathology plays a critical role in lethality associated with TSS. However, the molecular pathways by which INF-¿ contributes to lethality in TSS, either directly or indirectly through other mediators, are not clear. Therefore, it is proposed to (1) Delineate th mechanisms by which IFN-¿ plays a lethal role in staphylococcal SAg-induced TSS. This will be achieved by generating bone marrow chimeras between HLA-DR3.IFN-?R+/+ and HLA-DR3.IFN-?R-/- mice. Bone marrow chimeras will be challenged with SEB and several molecular pathways will be compared. However, IFN-? is also important for immunity S. aureus infections. Therefore, it is proposed to (2) Determine the role of IFN-? in the pathogenesis and immunity to MRSA-induced pneumonia and sepsis. This wil be accomplished by inducing pneumonia and sepsis in HLA-DR3.IFN-?+/+ and HLA-DR3.IFN-?R-/- mice with the MRSA isolate, USA300. Several bacteriological, immunological, biochemical and pathological parameters including mortality will be compared between these two lines of mice. It is known that HLA class II polymorphisms could strongly influence the magnitude of T cell activation and IFN-? production in response to streptococcal SAg. However, the impact of HLA-DR and HLA-DQ polymorphisms on staphylococcal SAg-driven immuneresponses has not been investigated. Therefore, it is proposed to (3) Determine the extent to which staphylococcal superantigen-induced IFN-? production is modulated by HLA class II polymorphisms thereby influencing the outcome of MRSA-induced pneumonia and sepsis. This will be investigated by a series of in vivo studies using transgenic mice expressing HLA-DR2, HLA-DR3, HLA-DR4, HLA-DQ2, HLA-DQ6 or HLA-DQ8 molecules.
PUBLIC HEALTH RELEVANCE: Staphylococcus aureus is a common, yet potentially dangerous bacterium. The occurrence of serious infections caused by the antibiotic resistant strains is increasing worldwide, which could be partly attributed to the ability of these strains t produce several harmful toxins. This study investigates the mechanisms of action of one such family of toxins called "superantigens". Also, the reasons as to why and how certain individuals might have different outcomes following an S. aureus infection will be studied using our humanized mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A humanized transgenic mouse model for studying staphylococcal enterotoxin B
-
批准号:7497343
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mouse models for S. aureus infections and superantigens
-
批准号:8646845
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mice as models for bacterial superantigen induced disease
-
批准号:7382578
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mouse models for S. aureus infections and superantigens
-
批准号:8468981
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mice as models for bacterial superantigen induced disease
-
批准号:7596265
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mice as models for bacterial superantigen induced disease
-
批准号:8033187
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mice as models for bacterial superantigen induced disease
-
批准号:7792489
-
项目类别:
-
资助金额:$21.56万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mice as models for bacterial superantigen induced disease
-
批准号:7212656
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2007
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA class II genes in demyelination
-
批准号:7099930
-
项目类别:
-
资助金额:$19.98万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA class II genes in demyelination
-
批准号:7193400
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA Class II Genes in Demyelination
-
批准号:8036554
-
项目类别:
-
资助金额:$34.5万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA class II genes in demyelination
-
批准号:7432539
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA class II genes in demyelination
-
批准号:7587522
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA Class II Genes in Demyelination
-
批准号:8715867
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA Class II Genes in Demyelination
-
批准号:8145634
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA Class II Genes in Demyelination
-
批准号:8306283
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
Role of HLA Class II Genes in Demyelination
-
批准号:8544508
-
项目类别:
-
资助金额:$32.62万
-
财政年份:2006
-
负责人:CHELLA S DAVID
-
依托单位:
HLA class II transgenic mice as experimental model of MS
-
批准号:6652311
-
项目类别:
-
资助金额:$19.52万
-
财政年份:2002
-
负责人:CHELLA S DAVID
-
依托单位:
Core--Transgenic animal model
-
批准号:6652313
-
项目类别:
-
资助金额:$19.52万
-
财政年份:2002
-
负责人:CHELLA S DAVID
-
依托单位:
Core--Transgenic animal model
-
批准号:6481263
-
项目类别:
-
资助金额:$19.52万
-
财政年份:2001
-
负责人:CHELLA S DAVID
-
依托单位:
海外基金